nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP2A6—Prednisolone—atopic dermatitis	0.066	0.0849	CbGbCtD
Dapagliflozin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0517	0.0665	CbGbCtD
Dapagliflozin—ABCB1—Tacrolimus—atopic dermatitis	0.0513	0.066	CbGbCtD
Dapagliflozin—CYP1A2—Diphenhydramine—atopic dermatitis	0.0429	0.0552	CbGbCtD
Dapagliflozin—CYP2A6—Dexamethasone—atopic dermatitis	0.0389	0.0501	CbGbCtD
Dapagliflozin—CYP2C9—Loratadine—atopic dermatitis	0.0387	0.0498	CbGbCtD
Dapagliflozin—CYP2C9—Diphenhydramine—atopic dermatitis	0.0387	0.0498	CbGbCtD
Dapagliflozin—ABCB1—Loratadine—atopic dermatitis	0.0376	0.0483	CbGbCtD
Dapagliflozin—CYP2D6—Loratadine—atopic dermatitis	0.0354	0.0455	CbGbCtD
Dapagliflozin—CYP2D6—Diphenhydramine—atopic dermatitis	0.0354	0.0455	CbGbCtD
Dapagliflozin—ABCB1—Methylprednisolone—atopic dermatitis	0.0343	0.0442	CbGbCtD
Dapagliflozin—CYP1A1—Dexamethasone—atopic dermatitis	0.0333	0.0428	CbGbCtD
Dapagliflozin—CYP3A4—Tacrolimus—atopic dermatitis	0.0307	0.0395	CbGbCtD
Dapagliflozin—CYP3A4—Loratadine—atopic dermatitis	0.0225	0.0289	CbGbCtD
Dapagliflozin—ABCB1—Betamethasone—atopic dermatitis	0.0223	0.0287	CbGbCtD
Dapagliflozin—ABCB1—Prednisolone—atopic dermatitis	0.022	0.0283	CbGbCtD
Dapagliflozin—ABCB1—Hydrocortisone—atopic dermatitis	0.0209	0.0269	CbGbCtD
Dapagliflozin—ABCB1—Prednisone—atopic dermatitis	0.0208	0.0268	CbGbCtD
Dapagliflozin—CYP3A4—Methylprednisolone—atopic dermatitis	0.0206	0.0265	CbGbCtD
Dapagliflozin—CYP3A4—Triamcinolone—atopic dermatitis	0.0156	0.0201	CbGbCtD
Dapagliflozin—CYP2C9—Dexamethasone—atopic dermatitis	0.0134	0.0172	CbGbCtD
Dapagliflozin—CYP3A4—Betamethasone—atopic dermatitis	0.0134	0.0172	CbGbCtD
Dapagliflozin—CYP3A4—Prednisolone—atopic dermatitis	0.0132	0.017	CbGbCtD
Dapagliflozin—ABCB1—Dexamethasone—atopic dermatitis	0.013	0.0167	CbGbCtD
Dapagliflozin—CYP3A4—Hydrocortisone—atopic dermatitis	0.0125	0.0161	CbGbCtD
Dapagliflozin—CYP3A4—Prednisone—atopic dermatitis	0.0125	0.016	CbGbCtD
Dapagliflozin—CYP2D6—Dexamethasone—atopic dermatitis	0.0122	0.0157	CbGbCtD
Dapagliflozin—CYP3A4—Dexamethasone—atopic dermatitis	0.00778	0.01	CbGbCtD
Dapagliflozin—Influenza—Tacrolimus—atopic dermatitis	0.000813	0.00373	CcSEcCtD
Dapagliflozin—Angina pectoris—Tacrolimus—atopic dermatitis	0.000792	0.00364	CcSEcCtD
Dapagliflozin—Extravasation—Betamethasone—atopic dermatitis	0.000791	0.00364	CcSEcCtD
Dapagliflozin—Extravasation—Dexamethasone—atopic dermatitis	0.000791	0.00364	CcSEcCtD
Dapagliflozin—Fungal infection—Prednisone—atopic dermatitis	0.000779	0.00358	CcSEcCtD
Dapagliflozin—Dysuria—Tacrolimus—atopic dermatitis	0.00076	0.00349	CcSEcCtD
Dapagliflozin—Rash—Desonide—atopic dermatitis	0.000758	0.00348	CcSEcCtD
Dapagliflozin—Dermatitis—Desonide—atopic dermatitis	0.000758	0.00348	CcSEcCtD
Dapagliflozin—Angioedema—Loratadine—atopic dermatitis	0.000757	0.00348	CcSEcCtD
Dapagliflozin—Headache—Desonide—atopic dermatitis	0.000753	0.00346	CcSEcCtD
Dapagliflozin—Constipation—Dimenhydrinate—atopic dermatitis	0.000751	0.00345	CcSEcCtD
Dapagliflozin—Constipation—Diphenhydramine—atopic dermatitis	0.000751	0.00345	CcSEcCtD
Dapagliflozin—Pollakiuria—Tacrolimus—atopic dermatitis	0.000751	0.00345	CcSEcCtD
Dapagliflozin—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.000745	0.00342	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000733	0.00337	CcSEcCtD
Dapagliflozin—Constipation—Pimecrolimus—atopic dermatitis	0.000726	0.00334	CcSEcCtD
Dapagliflozin—Infestation NOS—Tacrolimus—atopic dermatitis	0.000725	0.00333	CcSEcCtD
Dapagliflozin—Infestation—Tacrolimus—atopic dermatitis	0.000725	0.00333	CcSEcCtD
Dapagliflozin—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.000721	0.00331	CcSEcCtD
Dapagliflozin—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000718	0.0033	CcSEcCtD
Dapagliflozin—Hypertension—Loratadine—atopic dermatitis	0.000716	0.00329	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Tacrolimus—atopic dermatitis	0.000714	0.00328	CcSEcCtD
Dapagliflozin—Renal failure—Tacrolimus—atopic dermatitis	0.000712	0.00327	CcSEcCtD
Dapagliflozin—Myocardial infarction—Tacrolimus—atopic dermatitis	0.00071	0.00326	CcSEcCtD
Dapagliflozin—Urinary tract infection—Tacrolimus—atopic dermatitis	0.000704	0.00324	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.000701	0.00322	CcSEcCtD
Dapagliflozin—Urticaria—Dimenhydrinate—atopic dermatitis	0.000698	0.00321	CcSEcCtD
Dapagliflozin—Urticaria—Diphenhydramine—atopic dermatitis	0.000698	0.00321	CcSEcCtD
Dapagliflozin—Discomfort—Loratadine—atopic dermatitis	0.000697	0.0032	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Prednisolone—atopic dermatitis	0.00069	0.00317	CcSEcCtD
Dapagliflozin—Back pain—Mometasone—atopic dermatitis	0.000688	0.00316	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Loratadine—atopic dermatitis	0.000677	0.00311	CcSEcCtD
Dapagliflozin—Urticaria—Pimecrolimus—atopic dermatitis	0.000675	0.0031	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Hydrocortisone—atopic dermatitis	0.000674	0.0031	CcSEcCtD
Dapagliflozin—Body temperature increased—Pimecrolimus—atopic dermatitis	0.000671	0.00309	CcSEcCtD
Dapagliflozin—Skin disorder—Loratadine—atopic dermatitis	0.000657	0.00302	CcSEcCtD
Dapagliflozin—Angioedema—Mometasone—atopic dermatitis	0.00065	0.00299	CcSEcCtD
Dapagliflozin—Dizziness—Fluocinonide—atopic dermatitis	0.000644	0.00296	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Tacrolimus—atopic dermatitis	0.000642	0.00295	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.000639	0.00294	CcSEcCtD
Dapagliflozin—Urethral disorder—Tacrolimus—atopic dermatitis	0.000638	0.00293	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Triamcinolone—atopic dermatitis	0.000635	0.00292	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Methylprednisolone—atopic dermatitis	0.000634	0.00291	CcSEcCtD
Dapagliflozin—Hypotension—Loratadine—atopic dermatitis	0.000632	0.00291	CcSEcCtD
Dapagliflozin—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000626	0.00288	CcSEcCtD
Dapagliflozin—Rash—Fluocinonide—atopic dermatitis	0.000614	0.00282	CcSEcCtD
Dapagliflozin—Dermatitis—Fluocinonide—atopic dermatitis	0.000614	0.00282	CcSEcCtD
Dapagliflozin—Headache—Fluocinonide—atopic dermatitis	0.00061	0.0028	CcSEcCtD
Dapagliflozin—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.000608	0.00279	CcSEcCtD
Dapagliflozin—Infection—Fluocinolone Acetonide—atopic dermatitis	0.000604	0.00278	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000584	0.00268	CcSEcCtD
Dapagliflozin—Dizziness—Dimenhydrinate—atopic dermatitis	0.000581	0.00267	CcSEcCtD
Dapagliflozin—Dizziness—Diphenhydramine—atopic dermatitis	0.000581	0.00267	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Mometasone—atopic dermatitis	0.000581	0.00267	CcSEcCtD
Dapagliflozin—Constipation—Loratadine—atopic dermatitis	0.000579	0.00266	CcSEcCtD
Dapagliflozin—Infection—Mometasone—atopic dermatitis	0.000577	0.00265	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Betamethasone—atopic dermatitis	0.000576	0.00265	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Dexamethasone—atopic dermatitis	0.000576	0.00265	CcSEcCtD
Dapagliflozin—Malnutrition—Tacrolimus—atopic dermatitis	0.000566	0.0026	CcSEcCtD
Dapagliflozin—Rash—Diphenhydramine—atopic dermatitis	0.000554	0.00255	CcSEcCtD
Dapagliflozin—Rash—Dimenhydrinate—atopic dermatitis	0.000554	0.00255	CcSEcCtD
Dapagliflozin—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000553	0.00254	CcSEcCtD
Dapagliflozin—Dermatitis—Diphenhydramine—atopic dermatitis	0.000553	0.00254	CcSEcCtD
Dapagliflozin—Headache—Dimenhydrinate—atopic dermatitis	0.00055	0.00253	CcSEcCtD
Dapagliflozin—Headache—Diphenhydramine—atopic dermatitis	0.00055	0.00253	CcSEcCtD
Dapagliflozin—Back pain—Tacrolimus—atopic dermatitis	0.000548	0.00252	CcSEcCtD
Dapagliflozin—Rash—Pimecrolimus—atopic dermatitis	0.000536	0.00246	CcSEcCtD
Dapagliflozin—Dermatitis—Pimecrolimus—atopic dermatitis	0.000535	0.00246	CcSEcCtD
Dapagliflozin—Body temperature increased—Loratadine—atopic dermatitis	0.000535	0.00246	CcSEcCtD
Dapagliflozin—Headache—Pimecrolimus—atopic dermatitis	0.000532	0.00245	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000525	0.00241	CcSEcCtD
Dapagliflozin—Nausea—Dimenhydrinate—atopic dermatitis	0.000522	0.0024	CcSEcCtD
Dapagliflozin—Nausea—Diphenhydramine—atopic dermatitis	0.000522	0.0024	CcSEcCtD
Dapagliflozin—Nausea—Pimecrolimus—atopic dermatitis	0.000505	0.00232	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Prednisone—atopic dermatitis	0.000502	0.00231	CcSEcCtD
Dapagliflozin—Hypertension—Tacrolimus—atopic dermatitis	0.000489	0.00225	CcSEcCtD
Dapagliflozin—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000481	0.00221	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000479	0.0022	CcSEcCtD
Dapagliflozin—Influenza—Triamcinolone—atopic dermatitis	0.000477	0.00219	CcSEcCtD
Dapagliflozin—Discomfort—Tacrolimus—atopic dermatitis	0.000476	0.00219	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000462	0.00212	CcSEcCtD
Dapagliflozin—Oedema—Tacrolimus—atopic dermatitis	0.000462	0.00212	CcSEcCtD
Dapagliflozin—Infection—Tacrolimus—atopic dermatitis	0.000459	0.00211	CcSEcCtD
Dapagliflozin—Body temperature increased—Mometasone—atopic dermatitis	0.000459	0.00211	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000456	0.0021	CcSEcCtD
Dapagliflozin—Myocardial infarction—Prednisolone—atopic dermatitis	0.000454	0.00208	CcSEcCtD
Dapagliflozin—Infestation—Hydrocortisone—atopic dermatitis	0.000452	0.00208	CcSEcCtD
Dapagliflozin—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000452	0.00208	CcSEcCtD
Dapagliflozin—Skin disorder—Tacrolimus—atopic dermatitis	0.000449	0.00206	CcSEcCtD
Dapagliflozin—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000448	0.00206	CcSEcCtD
Dapagliflozin—Dizziness—Loratadine—atopic dermatitis	0.000447	0.00206	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000447	0.00205	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.000446	0.00205	CcSEcCtD
Dapagliflozin—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000443	0.00204	CcSEcCtD
Dapagliflozin—Hypotension—Tacrolimus—atopic dermatitis	0.000432	0.00198	CcSEcCtD
Dapagliflozin—Rash—Loratadine—atopic dermatitis	0.000427	0.00196	CcSEcCtD
Dapagliflozin—Dermatitis—Loratadine—atopic dermatitis	0.000426	0.00196	CcSEcCtD
Dapagliflozin—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000425	0.00195	CcSEcCtD
Dapagliflozin—Infestation—Methylprednisolone—atopic dermatitis	0.000425	0.00195	CcSEcCtD
Dapagliflozin—Headache—Loratadine—atopic dermatitis	0.000424	0.00195	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.00042	0.00193	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000419	0.00192	CcSEcCtD
Dapagliflozin—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000417	0.00192	CcSEcCtD
Dapagliflozin—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000416	0.00191	CcSEcCtD
Dapagliflozin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000402	0.00185	CcSEcCtD
Dapagliflozin—Nausea—Loratadine—atopic dermatitis	0.000402	0.00185	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000399	0.00183	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000399	0.00183	CcSEcCtD
Dapagliflozin—Constipation—Tacrolimus—atopic dermatitis	0.000395	0.00182	CcSEcCtD
Dapagliflozin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000383	0.00176	CcSEcCtD
Dapagliflozin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000383	0.00176	CcSEcCtD
Dapagliflozin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000381	0.00175	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000381	0.00175	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000381	0.00175	CcSEcCtD
Dapagliflozin—Myocardial infarction—Betamethasone—atopic dermatitis	0.000379	0.00174	CcSEcCtD
Dapagliflozin—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000379	0.00174	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000375	0.00172	CcSEcCtD
Dapagliflozin—Urticaria—Tacrolimus—atopic dermatitis	0.000367	0.00169	CcSEcCtD
Dapagliflozin—Rash—Mometasone—atopic dermatitis	0.000366	0.00168	CcSEcCtD
Dapagliflozin—Dermatitis—Mometasone—atopic dermatitis	0.000366	0.00168	CcSEcCtD
Dapagliflozin—Body temperature increased—Tacrolimus—atopic dermatitis	0.000365	0.00168	CcSEcCtD
Dapagliflozin—Headache—Mometasone—atopic dermatitis	0.000364	0.00167	CcSEcCtD
Dapagliflozin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000361	0.00166	CcSEcCtD
Dapagliflozin—Malnutrition—Hydrocortisone—atopic dermatitis	0.000353	0.00162	CcSEcCtD
Dapagliflozin—SLC5A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000348	0.0721	CbGpPWpGaD
Dapagliflozin—Nausea—Mometasone—atopic dermatitis	0.000345	0.00158	CcSEcCtD
Dapagliflozin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00034	0.00156	CcSEcCtD
Dapagliflozin—Malnutrition—Methylprednisolone—atopic dermatitis	0.000332	0.00152	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000332	0.00152	CcSEcCtD
Dapagliflozin—Angioedema—Prednisolone—atopic dermatitis	0.00033	0.00152	CcSEcCtD
Dapagliflozin—Myocardial infarction—Prednisone—atopic dermatitis	0.00033	0.00151	CcSEcCtD
Dapagliflozin—Angioedema—Hydrocortisone—atopic dermatitis	0.000323	0.00148	CcSEcCtD
Dapagliflozin—Back pain—Triamcinolone—atopic dermatitis	0.000322	0.00148	CcSEcCtD
Dapagliflozin—Hypertension—Prednisolone—atopic dermatitis	0.000312	0.00143	CcSEcCtD
Dapagliflozin—Dizziness—Tacrolimus—atopic dermatitis	0.000306	0.0014	CcSEcCtD
Dapagliflozin—Hypertension—Hydrocortisone—atopic dermatitis	0.000305	0.0014	CcSEcCtD
Dapagliflozin—Discomfort—Prednisolone—atopic dermatitis	0.000304	0.0014	CcSEcCtD
Dapagliflozin—Angioedema—Triamcinolone—atopic dermatitis	0.000304	0.0014	CcSEcCtD
Dapagliflozin—Angioedema—Methylprednisolone—atopic dermatitis	0.000303	0.00139	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000299	0.00137	CcSEcCtD
Dapagliflozin—Discomfort—Hydrocortisone—atopic dermatitis	0.000297	0.00137	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Prednisone—atopic dermatitis	0.000297	0.00136	CcSEcCtD
Dapagliflozin—Oedema—Prednisolone—atopic dermatitis	0.000295	0.00136	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000295	0.00136	CcSEcCtD
Dapagliflozin—Rash—Tacrolimus—atopic dermatitis	0.000291	0.00134	CcSEcCtD
Dapagliflozin—Dermatitis—Tacrolimus—atopic dermatitis	0.000291	0.00134	CcSEcCtD
Dapagliflozin—Headache—Tacrolimus—atopic dermatitis	0.00029	0.00133	CcSEcCtD
Dapagliflozin—Oedema—Hydrocortisone—atopic dermatitis	0.000288	0.00132	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000288	0.00132	CcSEcCtD
Dapagliflozin—Hypertension—Triamcinolone—atopic dermatitis	0.000287	0.00132	CcSEcCtD
Dapagliflozin—Hypertension—Methylprednisolone—atopic dermatitis	0.000287	0.00132	CcSEcCtD
Dapagliflozin—Infection—Hydrocortisone—atopic dermatitis	0.000286	0.00132	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000285	0.00131	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000281	0.00129	CcSEcCtD
Dapagliflozin—Skin disorder—Hydrocortisone—atopic dermatitis	0.00028	0.00129	CcSEcCtD
Dapagliflozin—Discomfort—Triamcinolone—atopic dermatitis	0.00028	0.00129	CcSEcCtD
Dapagliflozin—Discomfort—Methylprednisolone—atopic dermatitis	0.000279	0.00128	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000279	0.00128	CcSEcCtD
Dapagliflozin—Angioedema—Betamethasone—atopic dermatitis	0.000276	0.00127	CcSEcCtD
Dapagliflozin—Angioedema—Dexamethasone—atopic dermatitis	0.000276	0.00127	CcSEcCtD
Dapagliflozin—Nausea—Tacrolimus—atopic dermatitis	0.000274	0.00126	CcSEcCtD
Dapagliflozin—Oedema—Triamcinolone—atopic dermatitis	0.000271	0.00125	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000271	0.00125	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000271	0.00124	CcSEcCtD
Dapagliflozin—Infection—Triamcinolone—atopic dermatitis	0.00027	0.00124	CcSEcCtD
Dapagliflozin—Hypotension—Hydrocortisone—atopic dermatitis	0.000269	0.00124	CcSEcCtD
Dapagliflozin—Infection—Methylprednisolone—atopic dermatitis	0.000269	0.00124	CcSEcCtD
Dapagliflozin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000263	0.00121	CcSEcCtD
Dapagliflozin—Malnutrition—Prednisone—atopic dermatitis	0.000263	0.00121	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000262	0.00121	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000262	0.0012	CcSEcCtD
Dapagliflozin—Hypertension—Betamethasone—atopic dermatitis	0.000261	0.0012	CcSEcCtD
Dapagliflozin—Hypertension—Dexamethasone—atopic dermatitis	0.000261	0.0012	CcSEcCtD
Dapagliflozin—Discomfort—Dexamethasone—atopic dermatitis	0.000254	0.00117	CcSEcCtD
Dapagliflozin—Discomfort—Betamethasone—atopic dermatitis	0.000254	0.00117	CcSEcCtD
Dapagliflozin—SLC5A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000254	0.0526	CbGpPWpGaD
Dapagliflozin—Hypotension—Methylprednisolone—atopic dermatitis	0.000253	0.00116	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000249	0.00114	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000246	0.00113	CcSEcCtD
Dapagliflozin—Oedema—Betamethasone—atopic dermatitis	0.000246	0.00113	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000246	0.00113	CcSEcCtD
Dapagliflozin—Oedema—Dexamethasone—atopic dermatitis	0.000246	0.00113	CcSEcCtD
Dapagliflozin—Infection—Dexamethasone—atopic dermatitis	0.000245	0.00112	CcSEcCtD
Dapagliflozin—Infection—Betamethasone—atopic dermatitis	0.000245	0.00112	CcSEcCtD
Dapagliflozin—Angioedema—Prednisone—atopic dermatitis	0.00024	0.0011	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000238	0.00109	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000238	0.00109	CcSEcCtD
Dapagliflozin—Urticaria—Prednisolone—atopic dermatitis	0.000234	0.00108	CcSEcCtD
Dapagliflozin—Hypotension—Betamethasone—atopic dermatitis	0.00023	0.00106	CcSEcCtD
Dapagliflozin—Hypotension—Dexamethasone—atopic dermatitis	0.00023	0.00106	CcSEcCtD
Dapagliflozin—Urticaria—Hydrocortisone—atopic dermatitis	0.000229	0.00105	CcSEcCtD
Dapagliflozin—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000228	0.00105	CcSEcCtD
Dapagliflozin—Hypertension—Prednisone—atopic dermatitis	0.000227	0.00104	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000222	0.00102	CcSEcCtD
Dapagliflozin—Discomfort—Prednisone—atopic dermatitis	0.000221	0.00102	CcSEcCtD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000219	0.0453	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000217	0.000999	CcSEcCtD
Dapagliflozin—Urticaria—Triamcinolone—atopic dermatitis	0.000216	0.000991	CcSEcCtD
Dapagliflozin—Urticaria—Methylprednisolone—atopic dermatitis	0.000215	0.000989	CcSEcCtD
Dapagliflozin—Body temperature increased—Triamcinolone—atopic dermatitis	0.000215	0.000986	CcSEcCtD
Dapagliflozin—Oedema—Prednisone—atopic dermatitis	0.000214	0.000986	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000214	0.000986	CcSEcCtD
Dapagliflozin—Infection—Prednisone—atopic dermatitis	0.000213	0.000979	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000213	0.000977	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000213	0.000977	CcSEcCtD
Dapagliflozin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000212	0.000976	CcSEcCtD
Dapagliflozin—Skin disorder—Prednisone—atopic dermatitis	0.000208	0.000957	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Prednisone—atopic dermatitis	0.000207	0.000953	CcSEcCtD
Dapagliflozin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.0002	0.000919	CcSEcCtD
Dapagliflozin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.0002	0.000917	CcSEcCtD
Dapagliflozin—Urticaria—Betamethasone—atopic dermatitis	0.000196	0.000899	CcSEcCtD
Dapagliflozin—Urticaria—Dexamethasone—atopic dermatitis	0.000196	0.000899	CcSEcCtD
Dapagliflozin—Dizziness—Prednisolone—atopic dermatitis	0.000195	0.000897	CcSEcCtD
Dapagliflozin—Body temperature increased—Betamethasone—atopic dermatitis	0.000195	0.000895	CcSEcCtD
Dapagliflozin—Body temperature increased—Dexamethasone—atopic dermatitis	0.000195	0.000895	CcSEcCtD
Dapagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000192	0.0398	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000192	0.0398	CbGpPWpGaD
Dapagliflozin—Dizziness—Hydrocortisone—atopic dermatitis	0.000191	0.000876	CcSEcCtD
Dapagliflozin—Rash—Prednisolone—atopic dermatitis	0.000186	0.000855	CcSEcCtD
Dapagliflozin—Dermatitis—Prednisolone—atopic dermatitis	0.000186	0.000854	CcSEcCtD
Dapagliflozin—Headache—Prednisolone—atopic dermatitis	0.000185	0.00085	CcSEcCtD
Dapagliflozin—Constipation—Prednisone—atopic dermatitis	0.000183	0.000843	CcSEcCtD
Dapagliflozin—Rash—Hydrocortisone—atopic dermatitis	0.000182	0.000835	CcSEcCtD
Dapagliflozin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000182	0.000834	CcSEcCtD
Dapagliflozin—Headache—Hydrocortisone—atopic dermatitis	0.000181	0.00083	CcSEcCtD
Dapagliflozin—Dizziness—Triamcinolone—atopic dermatitis	0.00018	0.000825	CcSEcCtD
Dapagliflozin—Dizziness—Methylprednisolone—atopic dermatitis	0.000179	0.000823	CcSEcCtD
Dapagliflozin—Nausea—Prednisolone—atopic dermatitis	0.000175	0.000806	CcSEcCtD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—GLB1—atopic dermatitis	0.000173	0.0358	CbGpPWpGaD
Dapagliflozin—Nausea—Hydrocortisone—atopic dermatitis	0.000171	0.000787	CcSEcCtD
Dapagliflozin—Rash—Triamcinolone—atopic dermatitis	0.000171	0.000786	CcSEcCtD
Dapagliflozin—Dermatitis—Triamcinolone—atopic dermatitis	0.000171	0.000786	CcSEcCtD
Dapagliflozin—Rash—Methylprednisolone—atopic dermatitis	0.000171	0.000785	CcSEcCtD
Dapagliflozin—Dermatitis—Methylprednisolone—atopic dermatitis	0.000171	0.000784	CcSEcCtD
Dapagliflozin—Urticaria—Prednisone—atopic dermatitis	0.00017	0.000783	CcSEcCtD
Dapagliflozin—Headache—Triamcinolone—atopic dermatitis	0.00017	0.000781	CcSEcCtD
Dapagliflozin—Headache—Methylprednisolone—atopic dermatitis	0.00017	0.00078	CcSEcCtD
Dapagliflozin—Body temperature increased—Prednisone—atopic dermatitis	0.00017	0.000779	CcSEcCtD
Dapagliflozin—Dizziness—Betamethasone—atopic dermatitis	0.000163	0.000748	CcSEcCtD
Dapagliflozin—Dizziness—Dexamethasone—atopic dermatitis	0.000163	0.000748	CcSEcCtD
Dapagliflozin—Nausea—Triamcinolone—atopic dermatitis	0.000161	0.000741	CcSEcCtD
Dapagliflozin—Nausea—Methylprednisolone—atopic dermatitis	0.000161	0.000739	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00016	0.0331	CbGpPWpGaD
Dapagliflozin—Hypersensitivity—Prednisone—atopic dermatitis	0.000158	0.000726	CcSEcCtD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000158	0.0327	CbGpPWpGaD
Dapagliflozin—Rash—Betamethasone—atopic dermatitis	0.000155	0.000714	CcSEcCtD
Dapagliflozin—Rash—Dexamethasone—atopic dermatitis	0.000155	0.000714	CcSEcCtD
Dapagliflozin—Dermatitis—Betamethasone—atopic dermatitis	0.000155	0.000713	CcSEcCtD
Dapagliflozin—Dermatitis—Dexamethasone—atopic dermatitis	0.000155	0.000713	CcSEcCtD
Dapagliflozin—Headache—Betamethasone—atopic dermatitis	0.000154	0.000709	CcSEcCtD
Dapagliflozin—Headache—Dexamethasone—atopic dermatitis	0.000154	0.000709	CcSEcCtD
Dapagliflozin—Nausea—Dexamethasone—atopic dermatitis	0.000146	0.000672	CcSEcCtD
Dapagliflozin—Nausea—Betamethasone—atopic dermatitis	0.000146	0.000672	CcSEcCtD
Dapagliflozin—Dizziness—Prednisone—atopic dermatitis	0.000142	0.000652	CcSEcCtD
Dapagliflozin—Rash—Prednisone—atopic dermatitis	0.000135	0.000621	CcSEcCtD
Dapagliflozin—Dermatitis—Prednisone—atopic dermatitis	0.000135	0.000621	CcSEcCtD
Dapagliflozin—Headache—Prednisone—atopic dermatitis	0.000134	0.000617	CcSEcCtD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—GLB1—atopic dermatitis	0.000131	0.0271	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—GLB1—atopic dermatitis	0.000131	0.0271	CbGpPWpGaD
Dapagliflozin—Nausea—Prednisone—atopic dermatitis	0.000127	0.000585	CcSEcCtD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000121	0.0251	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000121	0.0251	CbGpPWpGaD
Dapagliflozin—SLC5A4—Orphan transporters—PPARA—atopic dermatitis	0.000116	0.0241	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000115	0.0239	CbGpPWpGaD
Dapagliflozin—SLC5A1—Orphan transporters—PPARA—atopic dermatitis	8.81e-05	0.0183	CbGpPWpGaD
Dapagliflozin—SLC5A2—Orphan transporters—PPARA—atopic dermatitis	8.81e-05	0.0183	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	8.73e-05	0.0181	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	8.73e-05	0.0181	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.03e-05	0.0166	CbGpPWpGaD
Dapagliflozin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	7.67e-05	0.0159	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPAR Alpha Pathway—PPARA—atopic dermatitis	7.63e-05	0.0158	CbGpPWpGaD
Dapagliflozin—CYP1A1—Estrogen Receptor Pathway—PPARA—atopic dermatitis	7.63e-05	0.0158	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.86e-05	0.0121	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—GLB1—atopic dermatitis	4.89e-05	0.0101	CbGpPWpGaD
Dapagliflozin—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	4.86e-05	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.44e-05	0.0092	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.44e-05	0.0092	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—GLB1—atopic dermatitis	4.09e-05	0.00849	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ADSL—atopic dermatitis	3.92e-05	0.00814	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.89e-05	0.00806	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—GLB1—atopic dermatitis	3.7e-05	0.00768	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—GLB1—atopic dermatitis	3.7e-05	0.00768	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	3.28e-05	0.00679	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SLC11A1—atopic dermatitis	3.27e-05	0.00679	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GLB1—atopic dermatitis	3.1e-05	0.00643	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GLB1—atopic dermatitis	3.1e-05	0.00643	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	3.1e-05	0.00643	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ADSL—atopic dermatitis	2.97e-05	0.00617	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ADSL—atopic dermatitis	2.97e-05	0.00617	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	2.92e-05	0.00606	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	2.91e-05	0.00604	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.84e-05	0.00588	CbGpPWpGaD
Dapagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.82e-05	0.00585	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL13—atopic dermatitis	2.65e-05	0.0055	CbGpPWpGaD
Dapagliflozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.64e-05	0.00547	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SLC11A1—atopic dermatitis	2.48e-05	0.00514	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SLC11A1—atopic dermatitis	2.48e-05	0.00514	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	2.44e-05	0.00506	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—PPARA—atopic dermatitis	2.41e-05	0.00499	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GLB1—atopic dermatitis	2.4e-05	0.00497	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	2.35e-05	0.00488	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ADSL—atopic dermatitis	2.3e-05	0.00476	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL5—atopic dermatitis	2.27e-05	0.0047	CbGpPWpGaD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.25e-05	0.00467	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.15e-05	0.00446	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.15e-05	0.00446	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	2.12e-05	0.0044	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.99e-05	0.00413	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	1.88e-05	0.0039	CbGpPWpGaD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	1.74e-05	0.00361	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.68e-05	0.00348	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.67e-05	0.00347	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL10—atopic dermatitis	1.66e-05	0.00344	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CCR5—atopic dermatitis	1.65e-05	0.00343	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	1.62e-05	0.00336	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL4—atopic dermatitis	1.61e-05	0.00335	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	1.58e-05	0.00329	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	1.38e-05	0.00286	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	1.35e-05	0.0028	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PPARA—atopic dermatitis	1.33e-05	0.00275	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CCR5—atopic dermatitis	1.25e-05	0.0026	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CCR5—atopic dermatitis	1.25e-05	0.0026	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	1.22e-05	0.00253	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.22e-05	0.00253	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	1.2e-05	0.00249	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.15e-05	0.00238	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.14e-05	0.00237	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GLB1—atopic dermatitis	1.09e-05	0.00226	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.07e-05	0.00222	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.07e-05	0.00221	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ADSL—atopic dermatitis	1.05e-05	0.00217	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CD4—atopic dermatitis	1.04e-05	0.00215	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PPARA—atopic dermatitis	1.01e-05	0.00209	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PPARA—atopic dermatitis	1.01e-05	0.00209	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	9.75e-06	0.00202	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	9.32e-06	0.00193	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	9.07e-06	0.00188	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GLB1—atopic dermatitis	8.87e-06	0.00184	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	8.7e-06	0.0018	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL2—atopic dermatitis	8.67e-06	0.0018	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	8.57e-06	0.00178	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.53e-06	0.00177	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ADSL—atopic dermatitis	8.5e-06	0.00176	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CD4—atopic dermatitis	7.87e-06	0.00163	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CD4—atopic dermatitis	7.87e-06	0.00163	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PPARA—atopic dermatitis	7.77e-06	0.00161	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	7.77e-06	0.00161	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	7.77e-06	0.00161	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.29e-06	0.00151	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GLB1—atopic dermatitis	6.83e-06	0.00142	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ADSL—atopic dermatitis	6.55e-06	0.00136	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.46e-06	0.00134	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—atopic dermatitis	6.31e-06	0.00131	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	6.28e-06	0.0013	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.82e-06	0.00121	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	5.66e-06	0.00117	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—atopic dermatitis	5.62e-06	0.00116	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GLB1—atopic dermatitis	5.09e-06	0.00106	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADSL—atopic dermatitis	4.88e-06	0.00101	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—atopic dermatitis	4.26e-06	0.000883	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—atopic dermatitis	4.26e-06	0.000883	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GLB1—atopic dermatitis	4.07e-06	0.000843	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.94e-06	0.000816	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADSL—atopic dermatitis	3.9e-06	0.000808	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.83e-06	0.000794	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GLB1—atopic dermatitis	3.8e-06	0.000788	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.71e-06	0.000769	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.67e-06	0.000762	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADSL—atopic dermatitis	3.64e-06	0.000755	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PPARA—atopic dermatitis	3.54e-06	0.000734	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GLB1—atopic dermatitis	3.25e-06	0.000673	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.12e-06	0.000646	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADSL—atopic dermatitis	3.11e-06	0.000645	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PPARA—atopic dermatitis	2.88e-06	0.000596	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.82e-06	0.000584	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.77e-06	0.000574	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.51e-06	0.000519	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.4e-06	0.000498	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.37e-06	0.00049	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARA—atopic dermatitis	2.22e-06	0.00046	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARA—atopic dermatitis	1.65e-06	0.000343	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARA—atopic dermatitis	1.32e-06	0.000274	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.24e-06	0.000258	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.23e-06	0.000256	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.05e-06	0.000218	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARA—atopic dermatitis	8.13e-07	0.000169	CbGpPWpGaD
